The number of individual cases identified in EudraVigilance for COVID-19 VACCINE JANSSEN (AD26.COV2.S) is 72,524 (up to 12/05/2024)
Evaluating Condition
Number of individual cases by Age Group
Pivot Table Prompts
Sections
Age Group
Cases
%
Not Specified
4,929
6.8%
0-1 Month
19
0.0%
2 Months - 2 Years
53
0.1%
3-11 Years
6
0.0%
12-17 Years
123
0.2%
18-64 Years
62,292
85.9%
65-85 Years
4,673
6.4%
More than 85 Years
429
0.6%
Total
72,524
100.0%
saw.dll?DocPart&StateID=195896156
Evaluating Condition
Number of individual cases by Sex
Pivot Table Prompts
Sections
Sex
Cases
%
Female
38,103
52.5%
Male
31,612
43.6%
Not Specified
2,809
3.9%
Total
72,524
100.0%
saw.dll?DocPart&StateID=195896157
Evaluating Condition
Number of individual cases by Geographic Origin (EEA/Non-EEA)
Pivot Table Prompts
Sections
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area
60,198
83.0%
Non European Economic Area
12,326
17.0%
Not Specified
0
Total
72,524
100.0%
saw.dll?DocPart&StateID=195896158
Evaluating Condition
Number of individual cases by Reporter Group
Pivot Table Prompts
Sections
Reporter Group
Cases
%
Healthcare Professional
28,410
39.2%
Non Healthcare Professional
44,114
60.8%
Not Specified
0
Total
72,524
100.0%
saw.dll?DocPart&StateID=195896159
Evaluating Condition
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu
Evaluating Condition
Move a group to the "Groups with Permission" area to allow members to use this Saved Customization. Check the box next to a group to make this Saved Customization its default.
